- Home
- PPSI vs NRXP Comparison
PPSI vs NRXP Comparison
Compare PPSI & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- NRXP
- Stock Information
- Founded
- PPSI 2008
- NRXP 2015
- Country
- PPSI United States
- NRXP United States
- Employees
- PPSI N/A
- NRXP N/A
- Industry
- PPSI Electrical Products
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- PPSI Industrials
- NRXP Health Care
- Exchange
- PPSI Nasdaq
- NRXP Nasdaq
- Market Cap
- PPSI 30.0M
- NRXP 32.6M
- IPO Year
- PPSI N/A
- NRXP N/A
- Fundamental
- Price
- PPSI $2.71
- NRXP $3.34
- Analyst Decision
- PPSI Strong Buy
- NRXP Strong Buy
- Analyst Count
- PPSI 1
- NRXP 4
- Target Price
- PPSI $12.00
- NRXP $28.50
- AVG Volume (30 Days)
- PPSI 37.9K
- NRXP 240.0K
- Earning Date
- PPSI 05-15-2025
- NRXP 08-13-2025
- Dividend Yield
- PPSI 54.74%
- NRXP N/A
- EPS Growth
- PPSI N/A
- NRXP N/A
- EPS
- PPSI 2.84
- NRXP N/A
- Revenue
- PPSI $26,304,000.00
- NRXP N/A
- Revenue This Year
- PPSI $24.01
- NRXP N/A
- Revenue Next Year
- PPSI $19.25
- NRXP N/A
- P/E Ratio
- PPSI $0.96
- NRXP N/A
- Revenue Growth
- PPSI 439.46
- NRXP N/A
- 52 Week Low
- PPSI $2.25
- NRXP $1.10
- 52 Week High
- PPSI $7.00
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- PPSI 50.31
- NRXP 60.08
- Support Level
- PPSI $2.65
- NRXP $2.90
- Resistance Level
- PPSI $2.76
- NRXP $3.53
- Average True Range (ATR)
- PPSI 0.10
- NRXP 0.19
- MACD
- PPSI 0.00
- NRXP -0.03
- Stochastic Oscillator
- PPSI 61.54
- NRXP 84.13
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.